All Type of News
Doctors, government at odds
Despite the health regulators’ recent announcement that doctors will be required to issue a duplicate prescription after diagnosis and pharmacists may hand-write prescription information or print it on the prescriptio...
Thrice daily delivery system of drug weighs down wholesalers
Local wholesalers are adopting survival strategies to boost their sluggish drug sales by introducing a system of delivering drugs three time a day.
On-line shopping malls operated by wholesalers make it a rule to k...
Lipitor 30 tablets may be returned: Pfizer Korea
Pfizer Korea said Monday that it will accept all returned goods of Lipitor 30 tablets until the end of this month as its package unit as well as dosage form was changed to 28 tablets as a result of modified production...
30 wholesalers pledge to stop predatory pricing
The nation’ 30 wholesalers promised to keep the prices of best-selling 30 over-the-counter (OTC) drugs without selling the drugs below cost.
In a monthly meeting on Monday, the Pharmaceutical Development Conference...
Pharmacists lashes out at optional insurance
The National Association for Pharmacists (NAP) has criticized the Korean Medical Association (KMA) for claiming the optional insurance, which is deemed absurd and irrational.
“Doctors are backpedaling by voicing th...
Grund named to head Merck KoreaMerck Korea, the local affiliate of the German chemical and pharmaceutical giant, said Monday it has appointed as its chief executive officer, Michael Grund.
Grund, who has ...
|
Huon’s fatty liver treatment in local phase-2 trials
Huons Co. said Monday it will begin phase-2 clinical trials of HL-09, a treatment for fatty liver, here in Korea.
The phase-2 trials are designed to evaluate the safety and efficacy of HL-09 (Magnolia Obovata Bark ...
MDFS officials to meet pharmaceutical CEOs
The Ministry of Food and Drug Safety (MFDS) plans to hold a meeting with the heads of pharmaceutical firms on Thursday in an effort to strengthen a two-way communication with the domestic pharmaceutical industry.
T...
KDRA to move forward study on new biopharmaceuticals
The Korea Drug Research Association (KDRA) will conduct a study on the feasibility of new biotech projects in seven sectors – low molecular weight drugs, natural products, biological drugs, antibodies, regenerative dr...
Medical institutions urged to make opposition over reimbursement claim within 30 days
The nation’s hospitals and clinics should make oppositions to the screening results of the Health Insurance Review and Assessment Service (HIRA) over the former’s medical insurance claims within 30 days.
The HIRA s...
